Svenja Schneegans
Overview
Explore the profile of Svenja Schneegans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gotze J, Meissner K, Pereira-Veiga T, Belloum Y, Schneegans S, Kropidlowski J, et al.
J Exp Clin Cancer Res
. 2025 Jan;
44(1):14.
PMID: 39815324
Background: The lack of predictive biomarkers contributes notably to the poor outcomes of patients with pancreatic ductal adenocarcinoma (PDAC). Cancer-associated fibroblasts (CAFs) are the key components of the prominent PDAC...
2.
Schneegans S, Loptien J, Mojzisch A, Loreth D, Kretz O, Raschdorf C, et al.
J Exp Clin Cancer Res
. 2024 Apr;
43(1):110.
PMID: 38605423
Background: Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal...
3.
Smit D, Schneegans S, Pantel K
Clin Exp Metastasis
. 2024 Jan;
41(4):403-411.
PMID: 38281256
The concept of liquid biopsy analysis has been established more than a decade ago. Since the establishment of the term, tremendous advances have been achieved and plenty of methods as...
4.
Pereira-Veiga T, Schneegans S, Pantel K, Wikman H
Cell Rep
. 2022 Aug;
40(9):111298.
PMID: 36044866
Circulating tumor cells (CTCs) are the seeds of distant metastasis, and the number of CTCs detected in the blood of cancer patients is associated with a worse prognosis. CTCs face...
5.
Besler K, Weglarz A, Keller L, von Amsberg G, Bednarz-Knoll N, Offermann A, et al.
Clin Chem
. 2022 Jun;
68(7):973-983.
PMID: 35652463
Background: Revealing molecular mechanisms linked to androgen receptor activity can help to improve diagnosis and treatment of prostate cancer. Retinoic acid-induced 2 (RAI2) protein is thought to act as a...
6.
Loreth D, Schuette M, Zinke J, Mohme M, Piffko A, Schneegans S, et al.
Int J Mol Sci
. 2021 Jul;
22(13).
PMID: 34209696
Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood...
7.
Schneegans S, Luck L, Besler K, Bluhm L, Stadler J, Staub J, et al.
Mol Oncol
. 2020 Apr;
14(5):1001-1015.
PMID: 32246814
The combination of liquid biomarkers from a single blood tube can provide more comprehensive information on tumor development and progression in cancer patients compared to single analysis. Here, we evaluated...
8.
Koch C, Joosse S, Schneegans S, Wilken O, Janning M, Loreth D, et al.
Cancers (Basel)
. 2020 Feb;
12(2).
PMID: 32069934
Circulating tumor cells (CTCs) are promising tools for risk prediction and the monitoring of response to therapy in cancer patients. Within the EU/IMI CANCER-ID consortium, we validated CTC enrichment systems...
9.
Munsterberg J, Loreth D, Brylka L, Werner S, Karbanova J, Gandrass M, et al.
Neuro Oncol
. 2020 Feb;
22(7):955-966.
PMID: 32064501
Background: Brain metastasis (BM) in non-small-cell lung cancer (NSCLC) has a very poor prognosis. Recent studies have demonstrated the importance of cell adhesion molecules in tumor metastasis. The aim of...